OptiBiotix Lands Distribution Deal In Bulgaria

London-listed OptiBiotix (AIM:OPTI) Follow has signed a licensing agreement with Velinoff Pharma to distribute ProBiotix’s patented probiotic strain LPLDL® in Bulgaria. 

Under the agreement, Velinoff will promote the sale of probiotic supplements, CholBiome® and CholBiome®X3, which both contain the LPLDL® strain, under a non-exclusive licence to pharmacies, doctors and clinics across the country.

“We are pleased to announce the agreement with Velinoff which will strengthen LPLDL®’s presence in Bulgaria,” said Steve Prescott, Chief Executive of ProBiotix, the wholly-owned subsidiary of OptiBiotix.

Shares in OptiBiotix were trading flat at 42p during Thursday trading.

Read More

Telelink Business Services Plans IPOs In Bulgaria And Abroad

Bulgaria's Telelink Business Services is considering making an initial public offering of its shares on the Bulgarian Stock Exchange and on foreign...

Bulgarian Party Subsidies Reduced From 11 BGN Per Vote To 1 BGN

The deputies approved the drastic reduction in parties’ and coalitions’ state funding from BGN 11 to BGN 1 per actual vote. The...

Cargotec Announces €0.5 Million Investment In Bulgaria

Cargotec Bulgaria, a unit of Finland's Cargotec, is investing 1 million levs ($564,000/511,000 euro) in the expansion of its business services centre in...

Recent

Bulgaria’s Population Problem

Bulgaria is a country in Eastern Europe, more specifically the Balkans, it is currently going   through major economic changes. The country is the poorest...

Apple Pay Arrives In Bulgaria

Apple Pay makes its way to Bulgaria. The British fintech Monese has officially announced that it will start offering this service to...

Bulgarian Ministry Of Culture Is Inspecting Bozhkov’s Confiscated Collection

The Prosecutor's Office instructed the Ministry of Culture to inspect the collection of antique objects kept and exhibited in a museum by the Thrace...